Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat


Tytuł :
Delaying radiation therapy for prostate cancer unlikely to affect survival during coronavirus disease 2019.
Autorzy :
Printz C
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Jan 15; Vol. 127 (2), pp. 171.
Typ publikacji :
Letter
MeSH Terms :
SARS-CoV-2*
COVID-19/*complications
Prostatic Neoplasms/*complications
Prostatic Neoplasms/*mortality
COVID-19/virology ; Combined Modality Therapy ; Humans ; Male ; Prognosis ; Prostatic Neoplasms/radiotherapy ; Radiotherapy ; Time-to-Treatment ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Autorzy :
Kim IE Jr; Department of Urology, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Jang TL; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Kim S; Department of Biostatistics, Rutgers School of Public Health, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Modi PK; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Singer EA; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Elsamra SE; Department of Urology, Warren Alpert Medical School, Brown University, Providence, Rhode Island.; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Kim IY; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.; Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Dec 01; Vol. 126 (23), pp. 5114-5123. Date of Electronic Publication: 2020 Sep 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Mass Screening/*methods
Prostatic Neoplasms/*mortality
African Americans/statistics & numerical data ; Aged ; Early Detection of Cancer ; European Continental Ancestry Group/statistics & numerical data ; Humans ; Kallikreins/analysis ; Male ; Middle Aged ; Prostate-Specific Antigen/analysis ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/epidemiology ; Race Factors ; SEER Program ; United States
Czasopismo naukowe
Tytuł :
The risk factors of upgrading in prostate cancer.
Autorzy :
Çeker G; Department of Urology, Faculty of Medicine, University of Zonguldak Bülent Ecevit, Zonguldak, Turkey.
Çalışkan S; Department of Urology, Istanbul Reyap Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4432. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatectomy*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/surgery
Biopsy ; Humans ; Magnetic Resonance Imaging ; Male ; Risk Factors
Opinia redakcyjna
Tytuł :
Reply to The risk factors of upgrading in prostate cancer.
Autorzy :
Shoag JE; Department of Urology, Weill Cornell Medicine, New York, New York.
Cai PY; Department of Urology, Weill Cornell Medicine, New York, New York.
Gross MD; Department of Urology, Weill Cornell Medicine, New York, New York.
Gaffney C; Department of Urology, Weill Cornell Medicine, New York, New York.
Li D; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Mao J; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Nowels M; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Scherr DS; Department of Urology, Weill Cornell Medicine, New York, New York.
Sedrakyan A; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Hu JC; Department of Urology, Weill Cornell Medicine, New York, New York.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4432-4433. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatectomy*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/surgery
Biopsy ; Humans ; Magnetic Resonance Imaging ; Male ; Risk Factors
Opinia redakcyjna
Tytuł :
Risk of invasive prostate cancer and prostate cancer death in relatives of patients with prostatic borderline or in situ neoplasia: A nationwide cohort study.
Autorzy :
Xu X; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.
Fallah M; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, Malmo, Sweden.
Tian Y; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.
Mukama T; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.
Sundquist K; Center for Primary Health Care Research, Lund University, Malmo, Sweden.; Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Community-based Healthcare Research and Education, Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Sundquist J; Center for Primary Health Care Research, Lund University, Malmo, Sweden.; Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Community-based Healthcare Research and Education, Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Brenner H; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
Kharazmi E; Division of Preventive Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Primary Health Care Research, Lund University, Malmo, Sweden.; Statistical Genetics Group, Institute of Medical Biometry and Informatics, University Hospital Heidelberg, Heidelberg, Germany.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4371-4378. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms/*complications
Cohort Studies ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Risk Assessment
Czasopismo naukowe
Tytuł :
Obesity, race, and long-term prostate cancer outcomes.
Autorzy :
Vidal AC; Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.
Oyekunle T; Urology Section, Veterans Affairs Health Care System, Durham, North Carolina.; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
Howard LE; Urology Section, Veterans Affairs Health Care System, Durham, North Carolina.; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
De Hoedt AM; Urology Section, Veterans Affairs Health Care System, Durham, North Carolina.
Kane CJ; Urology Department, University of California at San Diego Health System, San Diego, California.
Terris MK; Section of Urology, Veterans Affairs Health Care System, Augusta, Georgia.; Section of Urology, Medical College of Georgia, Augusta, Georgia.
Cooperberg MR; Department of Urology, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Amling CL; Division of Urology, Oregon Health Sciences University, Portland, Oregon.
Klaassen Z; Section of Urology, Medical College of Georgia, Augusta, Georgia.
Freedland SJ; Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.; Urology Section, Veterans Affairs Health Care System, Durham, North Carolina.
Aronson WJ; Urology Section, Department of Surgery, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.; Department of Urology, University of California at Los Angeles School of Medicine, Los Angeles, California.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Aug 15; Vol. 126 (16), pp. 3733-3741. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local/*epidemiology
Obesity/*epidemiology
Prostatic Neoplasms/*epidemiology
Prostatic Neoplasms, Castration-Resistant/*epidemiology
African Americans/genetics ; Aged ; Body Mass Index ; Data Management ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/genetics ; Obesity/blood ; Obesity/complications ; Obesity/genetics ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/complications ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms, Castration-Resistant/complications ; Prostatic Neoplasms, Castration-Resistant/genetics ; Risk Factors
Czasopismo naukowe
Tytuł :
Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men.
Autorzy :
Weiner AB; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Vo AX; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Desai AS; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Hu JC; Department of Urology, New York Presbyterian-Weill Cornell Medical College, New York, New York, USA.
Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Schaeffer EM; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Jul 15; Vol. 126 (14), pp. 3229-3236. Date of Electronic Publication: 2020 Apr 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Registries*
Early Detection of Cancer/*methods
Mass Screening/*methods
Medicaid/*economics
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*diagnosis
Databases, Factual ; Health Services Accessibility ; Humans ; Insurance Coverage ; Male ; Medically Uninsured ; Middle Aged ; Patient Protection and Affordable Care Act ; Prostatic Neoplasms/epidemiology ; Retrospective Studies ; Risk ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
Autorzy :
Patel DN; Division of Urology, Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Howard LE; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Division of Urology, Veterans Affairs Medical Center, Durham, North Carolina, USA.
De Hoedt AM; Division of Urology, Veterans Affairs Medical Center, Durham, North Carolina, USA.
Amling CL; Department of Urology, Oregon Health and Science University, Portland, Oregon, USA.
Aronson WJ; Department of Urology, University of California at Los Angeles School of Medicine, Los Angeles, California, USA.; Urology Section, Department of Surgery, Veterans Affairs Greater Los Angeles, Los Angeles, California, USA.
Cooperberg MR; Department of Urology, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
Kane CJ; Urology Department, University of California at San Diego Health System, San Diego, California, USA.
Klaassen ZW; Section of Urology, Veterans Affairs Medical Center, Augusta, Georgia, USA.; Section of Urology, Augusta University, Augusta, Georgia, USA.
Terris MK; Section of Urology, Veterans Affairs Medical Center, Augusta, Georgia, USA.; Section of Urology, Augusta University, Augusta, Georgia, USA.
Freedland SJ; Division of Urology, Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Division of Urology, Veterans Affairs Medical Center, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Jul 15; Vol. 126 (14), pp. 3274-3280. Date of Electronic Publication: 2020 May 06.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Continental Population Groups*
Bone Neoplasms/*ethnology
Bone Neoplasms/*secondary
Prostatic Neoplasms, Castration-Resistant/*ethnology
Prostatic Neoplasms, Castration-Resistant/*mortality
Aged ; Aged, 80 and over ; Bone Neoplasms/complications ; Follow-Up Studies ; Fractures, Spontaneous/complications ; Humans ; Kaplan-Meier Estimate ; Male ; Prognosis ; Proportional Hazards Models ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Risk ; Spinal Cord Compression/complications
Czasopismo naukowe
Tytuł :
Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance.
Autorzy :
Shoag JE; Department of Urology, Weill Cornell Medicine, New York, New York.
Cai PY; Department of Urology, Weill Cornell Medicine, New York, New York.
Gross MD; Department of Urology, Weill Cornell Medicine, New York, New York.
Gaffney C; Department of Urology, Weill Cornell Medicine, New York, New York.
Li D; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Mao J; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Nowels M; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Scherr DS; Department of Urology, Weill Cornell Medicine, New York, New York.
Sedrakyan A; Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Hu JC; Department of Urology, Weill Cornell Medicine, New York, New York.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Jul 01; Vol. 126 (13), pp. 2986-2990. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Magnetic Resonance Imaging*
Prostatectomy*
Image-Guided Biopsy/*methods
Prostate/*pathology
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Humans ; Logistic Models ; Male ; Neoplasm Grading ; Odds Ratio ; Preoperative Period ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnostic imaging ; SEER Program
Czasopismo naukowe
Tytuł :
Equal access to health care reduces racial disparities in prostate cancer outcomes.
Autorzy :
Hoge CG; Department of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Sussman J; Department of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Sidana A; Department of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Sep 15; Vol. 126 (18), pp. 4256-4257. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Letter; Comment
MeSH Terms :
African Americans*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/therapy
Continental Population Groups ; European Continental Ancestry Group ; Health Services Accessibility ; Humans ; Male
Opinia redakcyjna
Tytuł :
Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer.
Autorzy :
Lundon DJ; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Dovey Z; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Tewari AK; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Sep 15; Vol. 126 (18), pp. 4257-4258. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Letter; Comment
MeSH Terms :
African Americans*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/therapy
European Continental Ancestry Group ; Health Services Accessibility ; Humans ; Male ; Social Class
Opinia redakcyjna
Tytuł :
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Autorzy :
Ito K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Kobayashi M; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Komiyama M; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Naito S; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Hashine K; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
Saito S; Department of Urology, Tokyo Medical Center, Tokyo, Japan.
Arai G; Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Shinohara M; Department of Urology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Shimizu N; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Satoh T; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Yamauchi A; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Tochigi T; Department of Urology, Miyagi Cancer Center, Natori, Japan.
Takezawa Y; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Fujimoto H; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Yokomizo A; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Kakimoto KI; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Fukui I; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Karasawa K; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Tsukamoto T; Sapporo Medical University School of Medicine, Sapporo, Japan.
Nozaki M; Department of Radiation Oncology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Hasumi M; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Ishiyama H; Department of Radiation and Radiation Oncology, Kitasato University, Sagamihara, Japan.
Ohtani M; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Kuwahara M; Sendai Jin-Hinyokika, Sendai, Japan.
Harada M; Kanagawa Cancer Center, Yokohama, Japan.
Ohashi Y; University of Tokyo, Tokyo, Japan.
Kotake T; Kotake Clinic, Osaka, Japan.
Kakizoe T; Japan Society for Cancer, Tokyo, Japan.
Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Yamanaka H; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Pokaż więcej
Corporate Authors :
National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer Investigators
Źródło :
Cancer [Cancer] 2020 Sep 01; Vol. 126 (17), pp. 3961-3971. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Androgen Antagonists/*administration & dosage
Neoadjuvant Therapy/*adverse effects
Neoplasm Recurrence, Local/*drug therapy
Prostatic Neoplasms/*drug therapy
Aged ; Androgen Antagonists/adverse effects ; Combined Modality Therapy ; Disease-Free Survival ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Proportional Hazards Models ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Radiotherapy, Conformal/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor.
Autorzy :
Printz C
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Sep 01; Vol. 126 (17), pp. 3893-3894.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*
Guidelines as Topic*
Prostatic Neoplasms/*diagnosis
Humans ; Male ; Prognosis ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Patterns of metastases of prostatic ductal adenocarcinoma.
Autorzy :
Ranasinghe WKB; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brooks NA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Elsheshtawi MA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Davis JW; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bathala TK; Division of Diagnostic Imaging, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tu SM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pisters LL; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chapin BF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Aug 15; Vol. 126 (16), pp. 3667-3673. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*diagnosis
Carcinoma, Ductal/*diagnosis
Lung Neoplasms/*diagnosis
Prostatic Neoplasms/*diagnosis
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/pathology ; Aged ; Carcinoma, Ductal/diagnostic imaging ; Carcinoma, Ductal/pathology ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/secondary ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Thorax/diagnostic imaging ; Thorax/pathology
Czasopismo naukowe
Tytuł :
Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer.
Autorzy :
Riviere PJ; Research Service, VA San Diego Health Care System, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California at San Diego, School of Medicine, La Jolla, California.
Rose BS; Research Service, VA San Diego Health Care System, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California at San Diego, School of Medicine, La Jolla, California.; Department of Urology, University of California at San Diego, School of Medicine, La Jolla, California.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Sep 15; Vol. 126 (18), pp. 4258. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Letter; Comment
MeSH Terms :
African Americans*
Prostatic Neoplasms*/therapy
European Continental Ancestry Group ; Health Services Accessibility ; Humans ; Male ; Social Class
Opinia redakcyjna
Tytuł :
Germline and somatic DNA repair gene alterations in prostate cancer.
Autorzy :
Dall'Era MA; Department of Urology, University of California at Davis, Sacramento, California.; University of California at Davis Comprehensive Cancer Center, Sacramento, California.
McPherson JD; University of California at Davis Comprehensive Cancer Center, Sacramento, California.
Gao AC; Department of Urology, University of California at Davis, Sacramento, California.; University of California at Davis Comprehensive Cancer Center, Sacramento, California.
DeVere White RW; Department of Urology, University of California at Davis, Sacramento, California.; University of California at Davis Comprehensive Cancer Center, Sacramento, California.
Gregg JP; University of California at Davis Comprehensive Cancer Center, Sacramento, California.; Foundation Medicine, Cambridge, Massachusetts.
Lara PN Jr; Department of Urology, University of California at Davis, Sacramento, California.; University of California at Davis Comprehensive Cancer Center, Sacramento, California.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Jul 01; Vol. 126 (13), pp. 2980-2985. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
DNA Repair/*genetics
Prostatic Neoplasms/*genetics
Ataxia Telangiectasia Mutated Proteins/genetics ; Bone Neoplasms/genetics ; Bone Neoplasms/secondary ; Brain Neoplasms/genetics ; Cyclin-Dependent Kinases/genetics ; DNA-Binding Proteins/genetics ; Exons ; Genes, BRCA1 ; Genes, BRCA2 ; Germ-Line Mutation ; Humans ; Introns ; Logistic Models ; Male ; MutS Homolog 2 Protein/genetics ; Prostatic Neoplasms/pathology ; Tissue Distribution/genetics
Czasopismo naukowe
Tytuł :
Validation of a subclassification for high-risk prostate cancer in a prospective cohort.
Autorzy :
Butler SS; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Dee EC; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Lamba N; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Sha ST; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Mahal BA; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; McGraw/Patterson Center for Population Sciences, Boston, Massachusetts.
Whitbeck A; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Makkar R; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Wangoe J; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Mouw KW; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Nguyen PL; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Muralidhar V; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 May 15; Vol. 126 (10), pp. 2132-2138. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostate-Specific Antigen/*metabolism
Prostatic Neoplasms/*mortality
Prostatic Neoplasms/*pathology
Aged ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Grading ; Prognosis ; Prospective Studies ; Prostatic Neoplasms/metabolism ; Survival Analysis
Czasopismo naukowe
Tytuł :
Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: Comparison of outcomes and predictors to identify potential candidates for active surveillance.
Autorzy :
Su ZT; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Patel HD; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Epstein JI; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Pavlovich CP; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Allaf ME; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Apr 15; Vol. 126 (8), pp. 1632-1639. Date of Electronic Publication: 2020 Feb 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Prostate/*pathology
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*pathology
Biopsy/methods ; Cohort Studies ; Humans ; Logistic Models ; Male ; Neoplasm Grading/methods ; Prostate/metabolism ; Prostate-Specific Antigen/metabolism ; Prostatectomy/methods ; Prostatic Neoplasms/metabolism ; Risk Assessment ; Watchful Waiting/methods
Czasopismo naukowe
Tytuł :
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself.
Autorzy :
Joshi SS; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 May 15; Vol. 126 (10), pp. 2322-2323. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Early Detection of Cancer ; Humans ; Incidence ; Male ; Obesity/epidemiology
Opinia redakcyjna
Tytuł :
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself.
Autorzy :
Butler SS; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Mahal BA; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 May 15; Vol. 126 (10), pp. 2321-2322. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Early Detection of Cancer ; Humans ; Incidence ; Male ; Obesity/epidemiology
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies